CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH), engineered for extended half-life and sustained bioactivity in research models. Widely studied in preclinical settings, it stimulates growth hormone secretion and elevates IGF-1 levels in test subjects. Researchers explore CJC-1295 in contexts of anti-aging biology, metabolic regulation, lean body mass maintenance, and cellular regeneration pathways. Its modified amino acid sequence provides resistance to enzymatic degradation, making it valuable for longitudinal GH research. Each batch supplied by PeptideBull is independently tested for purity and identity to ensure consistent research-grade quality. This compound is supplied exclusively for in-vitro and preclinical research. Not intended for human consumption, therapeutic application, or veterinary use.
Research Articles
CJC-1295 DAC Research: A Long-Acting GHRH Analog
Investigate CJC-1295 DAC, a synthetic GHRH analog with prolonged action. This article delves into its research mechanism...
CJC-1295 Ipamorelin Combination: GH Research Insights
Discover the science behind the CJC-1295 Ipamorelin combination for growth hormone research. Explore potential applicati...
CJC-1295 no DAC: Pulsatile Growth Hormone Research Insights
Discover the science behind CJC-1295 no DAC and its role in pulsatile growth hormone research. This article delves into...